Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.72 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | NEU2 | Q9Y3R4 | 3/20 | 0.47 |
| ▸ | NEU4 | Q8WWR8 | 2/20 | 0.47 |
| ▸ | NEU3 | Q9UQ49 | 2/20 | 0.47 |
| ▸ | NEU1 | Q99519 | 1/20 | 0.47 |
| ▸ | SELL | P14151 | 1/20 | 0.43 |
| ▸ | SELP | P16109 | 1/20 | 0.43 |
| ▸ | MAG | P20916 | 2/20 | 0.42 |
| ▸ | SIGLEC7 | Q9Y286 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sialic Acid SCHEMBL22412 | 1.00 | NANP (0.72) | NANPL3MBTL1NEU2NEU4NEU3 | |
| Sialic Acid SCHEMBL12391269 | 1.00 | NANP (0.72) | NANPL3MBTL1NEU2NEU4NEU3 | |
| Sialic Acid SCHEMBL22879166 | 1.00 | NANP (0.72) | NANPL3MBTL1NEU2NEU4NEU3 | |
| Sialic Acid SCHEMBL20299824 | 1.00 | NANP (0.72) | NANPL3MBTL1NEU2NEU4NEU3 | |
| Sialic Acid SCHEMBL23366253 | 1.00 | NANP (0.72) | NANPL3MBTL1NEU2NEU4NEU3 | |
| Sialic Acid SCHEMBL804644 | 1.00 | NANP (0.72) | NANPL3MBTL1NEU2NEU4NEU3 | |
| Sialic Acid SCHEMBL24274184 | 1.00 | NANP (0.72) | NANPL3MBTL1NEU2NEU4NEU3 | |
| Sialic Acid SCHEMBL22279106 | 1.00 | NANP (0.72) | NANPL3MBTL1NEU2NEU4NEU3 | |
| Sialic Acid SCHEMBL21067569 | 1.00 | NANP (0.72) | NANPL3MBTL1NEU2NEU4NEU3 | |
| Sialic Acid SCHEMBL22943658 | 1.00 | NANP (0.72) | NANPL3MBTL1NEU2NEU4NEU3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15767 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121271994-B | Preparation method and application of alpha-2, 3 sialyltransferase-mediated sugar chain site-directed conjugated antibody drug conjugate | Wuhan Tangzhi Pharmaceutical Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-121910745-B | Application of N-acetylneuraminic acid in preparation of drugs for treating methamphetamine addiction | JINAN UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122070830-A | Yeast beta-glucan composition for preventing and relieving upper respiratory tract infection | 安琪酵母股份有限公司 | 2026-05-22 | — | — | CN | claimed |
| EP-4742899-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | claimed |
| CN-122060020-A | Hypoglycemic peptide sheep milk powder and preparation method thereof | 陕西科技大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122038429-A | CRISPR-Cas9 mediated gene editing system and application thereof | 江南大学 | 2026-05-15 | — | — | CN | claimed |
| US-20260132407-A1 | VIVO SYNTHESIS OF SIALYLATED COMPOUNDS | INBIOSE N V (BE) | 2026-05-14 | — | — | US | claimed |
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| CN-122004478-A | Special diet for improving cardiovascular and cerebrovascular diseases and microcirculation disturbance and preparation method thereof | 新蔡县黄金搭档健康科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122004476-A | Elsholtzia ginseng compound peptide special diet for improving cardiovascular and cerebrovascular diseases and microcirculation disturbance and preparation method thereof | 河南追真堂健康产业有限公司 | 2026-05-12 | — | — | CN | claimed |
| EP-0136438-A2 | Ganglioside derivatives | THE WELLCOME FOUNDATION LIMITED (GB) | 1985-04-10 | — | — | EP | claimed |
| EP-0133694-A2 | Process for producing neuraminidase and method and reagent for the quantitative determination of a sialic acid-containing substance using neuraminidase | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1985-03-06 | — | — | EP | claimed |
| US-4501728-A | Masking of liposomes from RES recognition | TECHNOLOGY UNLIMITED, INC. (US) | 1985-02-26 | — | — | US | claimed |
| US-4485100-A | POLYPEPTIDES; ANTISHOCK, ANTIINFLAMMATORY AND EMPHYSEMIA TREATMENT | BAYER AKTIENGESELLSCHAFT (DE) | 1984-11-27 | — | — | US | claimed |
| US-4476119-A | STIMULANTS FOR NERVE REGENERATION; ENZYME ACTIVATORS; NERVOUS SYSTEM DISORDERS | FIDIA S.P.A. (IT) | 1984-10-09 | — | — | US | claimed |
| EP-0120328-A2 | Pharmaceutical compositions containing the cytidine monophosphate of 5-acetamido-3,5-dideoxy-D-glycero-D-galactononulosaminic acid | C.R.C. Compagnia di Ricerca Chimica S.p.A. (IT) | 1984-10-03 | — | — | EP | claimed |
| US-4447600-A | IMMUNOSUPPRESSIVE AGENTS | KANTO ISHI PHARMACEUTICAL CO., LTD. (JP) | 1984-05-08 | — | — | US | claimed |
| US-4410515-A | PHOSPHORUS AND CALCIUM METABOLISM | MASSACHUSETTS GENERAL HOSPITAL (US) | 1983-10-18 | — | — | US | claimed |
| US-4229571-A | FROM ENTEROBACTERIACEAE | KATSUNUMA NOBUHIKO | 1980-10-21 | — | — | US | claimed |
| US-4146603-A | TUMOR SPECIFIC GLYCOPROTEINS AND METHOD FOR DETECTING TUMORIGENIC CANCERS | RESEARCH CORPORATION (US) | 1979-03-27 | — | — | US | claimed |